Idea Proposed by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Targeting Gleevec resistance in CML patients: Tumor suppressor p53 suppressed miR-144/451 contributes to the gleevec sensitivity in CML, 7/November/2013, 7.03 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org